We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$460M
AUM Growth
+$25.9M
Cap. Flow
-$38.6M
Cap. Flow %
-8.38%
Top 10 Hldgs %
67.04%
Holding
43
New
Increased
7
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.7M
2
CVX icon
Chevron
CVX
+$4.98M
3
FATE icon
Fate Therapeutics
FATE
+$1.49M
4
BHC icon
Bausch Health
BHC
+$881K
5
MNKD icon
MannKind Corp
MNKD
+$642K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$9.89M
2
NEE icon
NextEra Energy
NEE
+$4.79M
3
GM icon
General Motors
GM
+$4.15M
4
WEC icon
WEC Energy
WEC
+$1.13M
5
UHAL icon
U-Haul Holding Co
UHAL
+$586K

Sector Composition

Rank Sector Weight
1 Healthcare 30.46%
2 Utilities 28.15%
3 Industrials 10.84%
4 Technology 9.94%
5 Financials 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL icon
1
U-Haul Holding Co
UHAL
$13.9B
$42.7M 9.28%
1,413,520
-20,000
-1% -$586K
NEE icon
2
NextEra Energy
NEE
$185B
$40.1M 8.71%
667,200
-80,000
-11% -$4.79M
AAPL icon
3
Apple
AAPL
$4.9T
$32M 6.95%
350,400
ABBV icon
4
AbbVie
ABBV
$450B
$31.7M 6.88%
322,549
+64,749
+25% +$5.7M
ALL icon
5
Allstate
ALL
$64.3B
$30M 6.53%
309,800
CMS icon
6
CMS Energy
CMS
$22.8B
$28.8M 6.26%
492,800
XEL icon
7
Xcel Energy
XEL
$49.2B
$27.3M 5.92%
436,100
DUK icon
8
Duke Energy
DUK
$97.5B
$25.8M 5.61%
323,000
MRK icon
9
Merck
MRK
$315B
$25.3M 5.49%
342,591
BHC icon
10
Bausch Health
BHC
$1.8B
$24.9M 5.41%
1,362,000
+50,000
+4% +$881K
ABT icon
11
Abbott
ABT
$175B
$23.3M 5.06%
254,600
PFE icon
12
Pfizer
PFE
$143B
$16.9M 3.68%
545,795
IBM icon
13
IBM
IBM
$200B
$13.8M 2.99%
119,244
SUPN icon
14
Supernus Pharmaceuticals
SUPN
$2.79B
$8.36M 1.82%
352,105
SIRI icon
15
SiriusXM
SIRI
$10.3B
$7.97M 1.73%
135,784
AVA icon
16
Avista
AVA
$3.45B
$7.59M 1.65%
208,500
GE icon
17
GE Aerospace
GE
$364B
$7.17M 1.56%
210,668
CMP icon
18
Compass Minerals
CMP
$1.24B
$6.83M 1.48%
140,000
CVX icon
19
Chevron
CVX
$373B
$5.23M 1.14%
58,600
+55,600
+1,853% +$4.98M
NEM icon
20
Newmont
NEM
$95.8B
$4.01M 0.87%
65,000
FATE icon
21
Fate Therapeutics
FATE
$324M
$3.43M 0.75%
100,000
+50,000
+100% +$1.49M
PRTK
22
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.96M 0.64%
566,552
+100,000
+21% +$444K
FOCL
23
EDAP TMS S.A.
FOCL
$204M
$2.04M 0.44%
825,536
RLI icon
24
RLI Corp
RLI
$5.66B
$1.87M 0.41%
45,600
ASH icon
25
Ashland
ASH
$3.14B
$1.73M 0.38%
25,000

Similar funds

Bruce & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Bruce & Co held 43 positions worth $460M, up 6% from $434M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bruce & Co withdrew a net $38.6M in Q2 2020, closing 3 positions and reducing 3 holdings. Its most notable exit was Allergan plc, an estimated $9.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co added an estimated $5.7M to AbbVie.

  • Bruce & Co added most to AbbVie in Q2 2020, an estimated $5.7M increase.
  • Bruce & Co's biggest Q2 2020 reduction was NextEra Energy, cutting an estimated $4.79M.
  • Bruce & Co fully exited Allergan plc in Q2 2020, selling an estimated $9.89M.
  • Bruce & Co's ten largest holdings make up 67% of its $460M portfolio in Q2 2020.
  • Bruce & Co opened 0 new positions and closed 3 in Q2 2020.
  • Bruce & Co's portfolio value rose 6% quarter-over-quarter to $460M.

Based on Bruce & Co's 13F filing for Q2 2020, filed 14 Aug 2020.